Patents Assigned to Universita degli Studi del Piemonte Orientale “Amedeo Avogadro”
  • Ligands of B7H receptor in the treatment of osteopenia and osteoporosis
    Patent number: 11230587
    Abstract: A novel use of ligands of B7h receptor in the treatment of osteoporosis or osteopenia is disclosed as well as the use of B7h receptor as target for the screening of pharmaceutical active agents useful in the treatment of osteopenia or osteoporosis.
    Type: Grant
    Filed: May 18, 2016
    Date of Patent: January 25, 2022
    Assignee: UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “AMEDEO AVOGADRO”
    Inventors: Umberto Dianzani, Casimiro Luca Gigliotti, Elena Boggio
  • Quinolin-4 (1H)-one derivatives as inhibitors of phosphatidylinositol 3-kinases
    Patent number: 8841288
    Abstract: Compounds of Formula (I): able to inhibit kinase activity, in particular Phosphatidylinositol 3-Kinases activity. The disclosure also relates to the use of compounds of Formula (I) for treatment of pathological conditions associated to alterations in Phosphatidylinositol 3-Kinases activity.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: September 23, 2014
    Assignees: Universtà Degli Studi di Torino, Università Degli Studi del Piemonte Orientale “Amedeo Avogadro”
    Inventors: Giovanni Sorba, Gian Cesare Tron, Ubaldina Galli, Alberto Massarotti, Emilio Hirsch, Elisa Ciraolo, Tracey Pirali
  • Anti-HGF-R antibodies and their use
    Patent number: 7556804
    Abstract: The present invention relates to monoclonal antibodies which recognize the chain of the HFG receptor with the agonist activity of the natural ligand. The invention also relates to the hybridoma which secretes said antibodies and to their therapeutic and diagnostic use.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: July 7, 2009
    Assignee: Universita degli Studi del Piemonte Orientale “Amedeo Avogadro”
    Inventor: Maria Giovanna Prat